ArticleRadiology and oncology2020

[18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab.

Damijan Valentinuzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.